We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+0.03%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$184M
AUM Growth
-$5.72M
Cap. Flow
-$3.3M
Cap. Flow %
-1.8%
Top 10 Hldgs %
49.88%
Holding
105
New
16
Increased
25
Reduced
26
Closed
9

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$1.54M
2
AMD icon
Advanced Micro Devices
AMD
+$1.11M
3
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$1.08M
4
BOXX icon
Alpha Architect 1-3 Month Box ETF
BOXX
+$773K
5
XNCR icon
Xencor
XNCR
+$712K

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$2.12M
2
ARGX icon
argenx
ARGX
+$1.81M
3
JNJ icon
Johnson & Johnson
JNJ
+$761K
4
VIR icon
Vir Biotechnology
VIR
+$642K
5
PANW icon
Palo Alto Networks
PANW
+$639K

Sector Composition

Rank Sector Weight
1 Healthcare 33.26%
2 Technology 15.1%
3 Communication Services 6.79%
4 Consumer Discretionary 3.39%
5 Financials 2.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QQQ icon
1
PUT
Invesco QQQ Trust
QQQ
$453B
$24.5M 13.37%
+68,500
New +$25.4M
MU icon
2
Micron Technology
MU
$930B
$11.1M 6.04%
163,000
+3,500
+2% +$234K
ARGX icon
3
argenx
ARGX
$53.4B
$10.8M 5.89%
22,000
-3,700
-14% -$1.81M
GOOG icon
4
Alphabet (Google) Class C
GOOG
$4.36T
$9.25M 5.04%
70,150
-1,500
-2% -$195K
REGN icon
5
Regeneron Pharmaceuticals
REGN
$78.5B
$8.95M 4.88%
10,875
-300
-3% -$236K
ABBV icon
6
AbbVie
ABBV
$443B
$6.63M 3.61%
44,500
-3,050
-6% -$448K
ITCI
7
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$5.58M 3.04%
107,157
– –
ET icon
8
Energy Transfer Partners
ET
$70.1B
$5.23M 2.85%
373,000
-4,000
-1% -$53.1K
XNCR icon
9
Xencor
XNCR
$1.5B
$4.96M 2.7%
246,300
+31,300
+15% +$712K
ORCL icon
10
Oracle
ORCL
$374B
$4.5M 2.45%
42,500
-500
-1% -$57.9K
AMD icon
11
Advanced Micro Devices
AMD
$776B
$4.18M 2.28%
40,700
+10,200
+33% +$1.11M
LLY icon
12
Eli Lilly
LLY
$1.02T
$4.03M 2.19%
7,500
– –
PRTA icon
13
Prothena Corp
PRTA
$425M
$4M 2.18%
82,950
-1,800
-2% -$107K
GLD icon
14
SPDR Gold Trust
GLD
$131B
$3.69M 2.01%
21,500
– –
BAC icon
15
Bank of America
BAC
$435B
$3.55M 1.93%
129,500
-7,750
-6% -$229K
IAU icon
16
iShares Gold Trust
IAU
$62.9B
$3.5M 1.91%
100,000
– –
INCY icon
17
Incyte
INCY
$24.2B
$2.57M 1.4%
44,500
+4,000
+10% +$252K
AAPL icon
18
Apple
AAPL
$4.54T
$2.53M 1.38%
14,750
– –
BMY icon
19
CALL
Bristol-Myers Squibb
BMY
$133B
$2.47M 1.35%
+42,600
New +$2.61M
SGEN
20
DELISTED
Seagen Inc. Common Stock
SGEN
$2.33M 1.27%
11,000
-650
-6% -$130K
AMGN icon
21
Amgen
AMGN
$208B
$2.26M 1.23%
8,400
-8,475
-50% -$2.12M
BABA icon
22
CALL
Alibaba
BABA
$293B
$2.17M 1.18%
25,000
+21,000
+525% +$1.92M
T icon
23
AT&T
T
$159B
$2.14M 1.17%
142,500
+15,000
+12% +$220K
SPY icon
24
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$2.14M 1.16%
5,000
-75,500
-94% -$33.6M
JQC icon
25
Nuveen Credit Strategies Income Fund
JQC
$704M
$2.13M 1.16%
420,000
+30,000
+8% +$152K
1
2 3 4 5

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, DCF Advisers held 105 positions worth $184M, down 3% from $189M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

DCF Advisers's Q3 2023 filing shows 16 new, 25 increased, 26 reduced and 9 closed positions. Its largest new stake was State Street SPDR S&P Biotech ETF: 13,500 shares worth $986K. The largest sale was Amgen, an estimated $2.12M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

  • DCF Advisers's largest Q3 2023 buy was State Street SPDR S&P Biotech ETF: 13,500 shares worth $986K.
  • DCF Advisers added most to iShares Russell 2000 ETF in Q3 2023, an estimated $1.54M increase.
  • DCF Advisers's biggest Q3 2023 reduction was Amgen, cutting an estimated $2.12M.
  • DCF Advisers fully exited Palo Alto Networks in Q3 2023, selling an estimated $639K.
  • DCF Advisers's ten largest holdings make up 50% of its $184M portfolio in Q3 2023.
  • DCF Advisers opened 16 new positions and closed 9 in Q3 2023.
  • DCF Advisers's portfolio value fell 3% quarter-over-quarter to $184M.

Based on DCF Advisers's 13F filing for Q3 2023, filed 13 Nov 2023.